Recap: CASI Pharmaceuticals Q4 Earnings
Recap: CASI Pharmaceuticals Q4 Earnings
CASI Pharmaceuticals (NASDAQ:CASI) reported its Q4 earnings results on Thursday, March 28, 2024 at 07:00 AM.
卡西製藥（納斯達克股票代碼：CASI）於2024年3月28日星期四上午7點公佈了其第四季度業績。
Here's what investors need to know about the announcement.
以下是投資者需要了解的有關該公告的信息。
Earnings
收益
CASI Pharmaceuticals missed estimated earnings by -88.0%, reporting an EPS of $-0.45 versus an estimate of $-0.24.
CASI Pharmicals未達到預期收益-88.0％，每股收益爲-0.45美元，而預期爲-0.24美元。
Revenue was down $8.38 million from the same period last year.
收入比去年同期下降了838萬美元。
Past Earnings Performance
過去的收益表現
Last quarter the company beat on EPS by $0.21 which was followed by a 3.0% drop in the share price the next day.
上個季度，該公司的每股收益高出0.21美元，隨後第二天股價下跌了3.0％。
Here's a look at CASI Pharmaceuticals's past performance:
以下是CASI Pharmicals過去的表現：
| Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.56 | -0.50 | -0.64 | -0.37 |
| EPS Actual | -0.35 | -0.77 | -0.45 | -1.44 |
| Revenue Estimate | 10.40M | 10.09M | 9.10M | 10.79M |
| Revenue Actual | 8.84M | 9.82M | 8.35M | 15.26M |
| 季度 | 2023 年第三季度 | 2023 年第二季度 | 2023年第一季度 | 2022 年第四季度 |
|---|---|---|---|---|
| 每股收益估算 | -0.56 | -0.50 | -0.64 | -0.37 |
| 實際每股收益 | -0.35 | -0.77 | -0.45 | -1.44 |
| 收入估算 | 10.40 米 | 10.09 億 | 9.10 米 | 10.79 億 |
| 實際收入 | 8.84 億 | 9.82 米 | 8.35M | 15.26 億 |
To track all earnings releases for CASI Pharmaceuticals visit their earnings calendar here.
要追蹤CASI製藥公司發佈的所有業績，請在此處訪問其業績日曆。
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自動內容引擎生成，並由編輯審閱。
譯文內容由第三人軟體翻譯。